Clinical trial
Accelerated Biological Aging is Associated With Increased Risk of T2DM in the MASLD Population: a Cohort Study
NCT06984510 is registered in ClinicalTrials.gov with Ningbo No. 1 Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Accelerated Biological Aging is Associated With Increased Risk of T2DM in the MASLD Population: a Cohort Study
- Lead sponsor
- Ningbo No. 1 Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 1, 2025
- Completion date
- December 31, 2025
- Enrollment
- 2,720 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
biological age, metabolic dysfunction-associated steatotic liver disease, type 2 diabetes mellitus (t2dm)